IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q2 2022 Holdings

Filed 2022-08-10 | 5 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$40.7M3,846,15499.5%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$161.9K1,111,1110.4%
Epizyme Inc(EPZMEUR)COM29428V104$46.8K31,841,3940.1%
Epizyme IncCallCOM29428V904$3.8K2,575,4500.0%
Viracta Therapeutics IncCOM92765F108$183,7000.0%